Novartis Q3 Preview: Zolgensma Back In The Spotlight

First sales of SMA gene therapy to be revealed

Novartis
Novartis sales in the spotlight on 22 October • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Earnings

More from Business